News >

FDA Approves Gardasil 9 HPV Vaccine for Use Up to Age 45

OncLive Staff
Published: Sunday, Oct 07, 2018

The HPV vaccine Gardasil 9 (HPV 9-valent Vaccine, Recombinant) is now approved by the FDA for use in males and females aged 9 through 45 years.1

The company also noted that “Gardasil 9 is contraindicated in individuals with hypersensitivity, including severe allergic reactions to yeast, or after a previous dose of Gardasil 9 or Gardasil."


  1. FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. FDA. Published October 5, 2018. Accessed October 7, 2018.
  2. FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for GARDASIL®9 in Women and Men Ages 27 to 45 for the Prevention of Certain HPV-Related Cancers and Diseases. Merck. Published June 13, 2018. Accessed October 7, 2018.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication